Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor

Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor

US Patent 9642796 · Granted May 9, 2017

Estimated economic value: $448,000,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-pi2023
Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-pi2023
Production of dosage forms comprising a solid dispersion of a microcrystalline a2020
Solid retard formulations based on solid dispersions2019